Prophylaxis for COVID-19
The MIC has had a number of enquiries from pharmacists receiving prescriptions for chloroquine for prophylaxis against COVID-19 in healthy people. Please note the statement below from the CDC website:
The COVID-19 Treatment Guidelines Panel recommends against the use of any agents for SARS-CoV-2 pre-exposure prophylaxis (PrEP), except in a clinical trial (AIII).
At present, no known agent that is administered before exposure (i.e., as PrEP) can prevent SARS-CoV-2 infection. Clinical trials are investigating several agents, including emtricitabine plus tenofovir alafenamide or tenofovir disoproxil fumarate, hydroxychloroquine, and supplements such as zinc, vitamin C, and vitamin D. Studies of monoclonal antibodies that target SARS-CoV-2 are in development. Please check ClinicalTrials.gov for the latest information
You can find the full guidelines on the NIH website.